͵͵

Journal News

How flame retardants could impair neurodevelopment

Anna Tancredi
Dec. 24, 2020

Evidence has been mounting for years that the flame retardants coating our furniture, electronics and construction materials are more harmful than helpful to human health. Members of one class of these retardants, polybrominated diphenyl ethers, or PBDEs, have come under increased scrutiny for their potential role in disrupting neurodevelopment, especially in children. Researchers have found that the 209 PBDE congeners can bioaccumulate in lipid-rich tissues, including in the brain, but the precise mechanism by which these compounds cause harm remains unknown.

Ramendra Saha, who effective Jan. 1 will be an associate professor of cellular and molecular biology at the University of California, Merced, first heard about PBDEs at the National Institute of Environmental Sciences, where he was a postdoctoral fellow. He listened to speaker after speaker describe the potential toxicity of these compounds that seemed to litter every home. As a new father at the time, he wondered how he could keep his son safe.

Armed with a background in neuroplasticity and transcription, Saha delved into the epigenetic effects of PBDEs in neuronal development and function.

Saha's lab found that certain PBDEs can act as promiscuous kinase inhibitors and disrupt a signaling pathway involved in cell growth, division and differentiation known as the mitogen-activated protein kinase extracellular signal-regulated kinase, or MEK–ERK, pathway.

"We were looking at environmental toxins that have been shown to have some correlation with intellectual disability and that act as an inhibitor to signaling cascades that are known to be important to normal neurodevelopment," Saha explained.

A paper in the Journal of Biological Chemistry describes the study in which Saha's team proposed a new mechanism by which one particularly toxic PBDE, 6-OH-BDE-47, known as 6-OH, could impair the MEK–ERK signaling pathway. Robert Poston, a Ph.D. student in Saha's lab at the time, noticed that MEK inhibitor PD0325901, or PD, had key chemical structures similar to 6-OH. Using 3D modeling software, the researchers simulated the binding interactions of both 6-OH and PD with MEK1.

The results were encouraging: 6-OH and PD both were calculated to bind in the same allosteric binding site for MEK1. When they tried to demonstrate this binding directly in the lab, however, they were stumped: Increasing amounts of 6-OH added to MEK1 did not lower MEK1 activity.

Teaming up with researchers at the University of Dundee in Scotland, they screened 6-OH with 140 kinases that represent most of the human kinome. Simulations of their top hits showed that 6-OH binding was most likely in the well-known ATP-binding pockets of the screened kinases, suggesting this PBDE could be a promiscuous ATP-competitive kinase inhibitor and could explain the complex and diverse effects of PBDE exposure.

Saha's group continues to study how 6-OH exposure can affect mitochondrial function, calcium homeostasis, regulation of synaptic function and other links to the impairment of MEK–ERK signaling.

Has Saha's work in the toxicology field changed his family's behavior? "Absolutely," he said. "We do not buy anything that is labeled 'fire resistant.'"

Though we might not be able to avoid PBDEs completely in items such as laptop computers, Saha suggests replacing old furniture and paying attention to consumer item labels to minimize exposure.

Saha-kinase-890x332.jpg
Poston et al. 2020
Ligand-docking simulation results for the top three hits from the kinase screen. Crystal structures were obtained from the Protein Data Bank, and Autodock-Vina was used to find energetically optimal binding poses for 6-OH (red) with each kinase. Top binding poses clustered largely to the well-known ATP-binding pockets of the kinases. 6-OH acting as an ATP-competitive kinase inhibitor may help to explain the complex and diverse effects documented for PBDE exposures.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Anna Tancredi

Anna Tancredi received a bachelor's degree in molecular biology from Kenyon College.

Related articles

From the Journals: JBC
Ankita Arora
From the Journals: JBC
Ken Farabaugh
From the journals: JBC
Ken Farabaugh
From the journals: JBC
Ken Farabaugh
From the journals: JBC
Ken Farabaugh
From the journals: JBC
Ken Farabaugh

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.

From the journals: JLR
Journal News

From the journals: JLR

Nov. 15, 2024

Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.